Clinical trial

Phase III Study to Evaluate the Efficacy and Safety of AD-209

NCT06348576

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-05-20

PhasePHASE3

Study timeline

Study start (actual)2024-05-20Date precision: day

Registry last updated2024-05-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension,Essentialunresolved

Interventions

AD-209DRUG

AD-2091DRUG

AD-209 PlaceboDRUG

AD-2091 PlaceboDRUG

Sponsors & collaborators

Addpharma Inc.lead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06348576 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.